A Serum‐Stable Antimicrobial Peptide‐Based Delivery Platform for Selective Treatment of Nontargetable and Chemoresistant Tumors

Abstract Antibody–drug conjugates (ADCs) have transformed cancer therapy but remain limited by their dependence on internalizing antigens, poor applicability to untargetable tumors, and susceptibility to drug resistance. Therefore, a modular antimicrobial‐peptide (AMP)‐based therapeutic system cente...

Descrición completa

Detalles Bibliográficos

Principais autores:	Tianxing Liu, Lingyu Ke, Ruize Sun, Xiaoling Chen, Mei Zhou, Olaf R. P. Bininda‐Emond, Chengbang Ma, Yangyang Jiang, Tao Wang, Chris Shaw, Lei Wang, Tianbao Chen, Alideertu Dong
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-12-01
Series:	Advanced Science
Assuntos:	activatable linkers antimicrobial peptides chemotherapy resistance membrane affinity reconstruction serum stability therapeutic window
Acceso en liña:	https://doi.org/10.1002/advs.202504710
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!